A Message From Behind the Markets

Dear Reader,

The chaos you're seeing?

It's not chaos at all.

I realized that after two private meetings with United States Congressmen — three days after 2,000 missiles rained on Iran.

March 2nd. Back-to-back meetings. No cameras. No staff.

And what I dug into afterward led me to something much larger than anyone on the news is reporting.

A coordinated Two-Front Economic War.

Already in motion.

I didn't want to believe the scale of what I found.

But after weeks of research…

It became undeniable.

Click here to uncover the hidden strategy behind the Iran war.

You can ignore this…

Or you can understand what's really happening — and position yourself before the clock runs out.

Go here now and decide for yourself.

Sincerely,

Dylan Jovine

Founder, Behind the Markets

Amprius Technologies' Next Big Rally Could Be Taking Shape

Author: Thomas Hughes. Originally Published: 10/20/2026.

Amprius Technologies (NYSE: AMPX) experienced a shocking trend shift in Q3 at face value, given the 68% correction in its share price over that period. During the quarter, shares were up as much as 3,877% from their 2024 lows, offering early investors a compelling profit opportunity. The stock remains significantly higher than it was at that time.

This stock's price action reflects a fundamental market shift that is still underway and likely to gain momentum in the coming quarters. Amprius Technologies’ technology has been validated, it is backed by government grants, the timeline for product ramp-up is accelerating, and profitability forecasts are improving alongside it. With the company now entering its execution phase, the upside potential is off the charts.

The Chart Says Speculation Phase Is Over, Execution Phase Underway

Amprius Technologies' chart action reveals that its first phase—the speculation phase—is complete or nearly so. The 2024-to-2026 price action clearly aligns with Elliott Wave Theory, showing a market waking up to the opportunity, buying into the outlook and then driving the stock to fresh highs on FOMO, or the fear of missing out.

Elliott Waves are a widely used technical tool based on an eight-wave cycle. The five-wave impulse cycle includes three upswings and two corrections, with the middle surge usually the largest; under a strict interpretation, it can never be the smallest. In this case, AMPX’s market swings are 490%, 550% and 215%, which perfectly matches the rule. The three-wave corrective phase is now underway, with the bottom clearly marked. The question is whether AMPX’s market has completed its corrective action or faces another test of support, which cannot be ruled out.

For investors, this suggests AMPX's market is likely near its bottom, as other indicators suggest. While AMPX hit fresh lows in mid-October, the market is diverging from its indicators and becoming overextended ahead of an expected series of bullish catalysts. In this scenario, the stock is set for a bullish swing with the potential to sustain an upward trajectory despite periodic pullbacks and corrections.

Upcoming catalysts include the Q3 2026 earnings report, due in early November. Quarterly results are likely to be strong, given the contract wins, ongoing capacity ramp-up and history of outperformance. Consensus forecasts call for only slight quarter-to-quarter growth and a slowdown to about 66.5% year-over-year, likely underestimating the company's strength. Guidance will be the more critical factor, as trends point to a surge in product availability next year. Analysts forecast only about 50% growth next year, another figure the company is likely to outperform.

AMPX’s Next Bullish Wave Could Send Shares Above $31

In a scenario where Amprius’ outlook continues to improve, completing the initial eight-wave Elliott cycle would mark the end of the second wave in a much larger movement. In this scenario, AMPX is positioned to advance by an amount equal to the first cycle—about $23.62 in the base case—and can easily exceed that amount if the news cycle cooperates. The bull case requires flawless or nearly flawless execution, supported by quarterly outperformance, steadily improving guidance and positive contract flow.

Adding the $23.62 projection to the mid-October lows puts AMPX above $31, with an accelerating timeline for reaching that level. As it stands, the bull case puts the stock at the target level by mid-2027, and analyst trends support that outlook. MarketBeat data reveals increasing coverage, a strengthening Moderate Buy rating among 13 tracked analysts and more than 170% upside to the consensus target. Consensus remains below $22, but the trend matters, with high-end targets in the $30-to-$33 range, bracketing the Elliott Wave projection.

Institutional investors remain a critical factor. The group does not own much of this stock yet and sold in early Q4, contributing to the price downdraft. If institutions do not get on board, retail investors will struggle to keep the stock price elevated after a rebound. The good news is that triggers for institutional buying exist, including executing on its government grant, securing full NDAA compliance and ramping NDAA-compliant production. The company has secured NDAA-compliant components; now it needs to ramp capacity and capability across its portfolio. Only a portion of its roughly two dozen designs are currently compliant.

Amprius Technologies' $75 million Department of War grant was a game-changer for investors. The move validated government interest, shifting the narrative from speculation to “we definitely want this,” and set the stage for a significant capacity ramp in early 2028. The deal aims to refit an existing electric vehicle battery facility to make AMPX cells, targeting annual production of 12 million cells.